Literature DB >> 20074754

Stage I Norwood: optimal technical performance improves outcomes irrespective of preoperative physiologic status or case complexity.

John M Karamichalis1, Ravi R Thiagarajan, Hua Liu, Petra Mamic, Kimberlee Gauvreau, Emile A Bacha.   

Abstract

OBJECTIVE: Interplay of baseline physiologic status, case complexity, technical performance, and outcomes in high-acuity operations has been poorly defined. This study explored these interactions to determine whether a technically optimal operation can mitigate effects of baseline physiology and high case-complexity on outcomes for the stage I Norwood procedure.
METHODS: Technical performance was categorized as optimal, adequate, or inadequate from adequacy of the anatomic repair of the stage I subprocedures according to anatomic areas where intervention is performed. Physiological illness severity statuses in preoperative and postoperative periods were determined with Pediatric Risk of Mortality III system, which uses 17 physiologic variables. Case complexity was calculated with Aristotle comprehensive system. All patients undergoing stage I procedure from January 2004 to December 2007 were retrospectively studied.
RESULTS: One hundred thirty-five procedures were included. Five were excluded from the technical performance assessment because of inadequate postoperative data. Eighty-one (62.3%), 26 (20%), and 23 (17.7%), respectively, were scored as optimal, adequate, and inadequate. Overall hospital mortality was 14.1%. Inadequate technical performance, high-complexity Aristotle comprehensive scores, and high preoperative illness severity scores correlated with significantly higher hospital mortality, longer stay, and greater frequency of major postoperative complications. In subgroup analysis of patients with optimal technical performance, outcomes were favorable irrespective of high or low preoperative physiologic illness severity or case complexity.
CONCLUSIONS: In stage I Norwood procedures, optimal technical performance attenuated effects of poor preoperative physiologic status and high case complexity, with reduced hospital mortality. Inadequate technical performance resulted in poor outcomes regardless of preoperative status. Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20074754     DOI: 10.1016/j.jtcvs.2009.10.011

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

Review 1.  Surgical volume-to-outcome relationship and monitoring of technical performance in pediatric cardiac surgery.

Authors:  David Kalfa; Paul Chai; Emile Bacha
Journal:  Pediatr Cardiol       Date:  2014-06-04       Impact factor: 1.655

2.  Relative impact of surgeon and center volume on early mortality after the Norwood operation.

Authors:  Christoph P Hornik; Xia He; Jeffrey P Jacobs; Jennifer S Li; Robert D B Jaquiss; Marshall L Jacobs; Sean M O'Brien; Karl Welke; Eric D Peterson; Sara K Pasquali
Journal:  Ann Thorac Surg       Date:  2012-04-18       Impact factor: 4.330

3.  Utility of a standardized postcardiopulmonary bypass epicardial echocardiography protocol for stage I Norwood palliation.

Authors:  Kenan W D Stern; Kimberlee Gauvreau; Sitaram Emani; Tal Geva
Journal:  Congenit Heart Dis       Date:  2017-02-16       Impact factor: 2.007

4.  Technical performance score is associated with outcomes after the Norwood procedure.

Authors:  Meena Nathan; Lynn A Sleeper; Richard G Ohye; Peter C Frommelt; Christopher A Caldarone; James S Tweddell; Minmin Lu; Gail D Pearson; J William Gaynor; Christian Pizarro; Ismee A Williams; Steven D Colan; Carolyn Dunbar-Masterson; Peter J Gruber; Kevin Hill; Jennifer Hirsch-Romano; Jeffrey P Jacobs; Jonathan R Kaltman; S Ram Kumar; David Morales; Scott M Bradley; Kirk Kanter; Jane W Newburger
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-19       Impact factor: 5.209

5.  Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart Disease.

Authors:  Meena Nathan; Jami C Levine; Maria I Van Rompay; Linda M Lambert; Felicia L Trachtenberg; Steven D Colan; Iki Adachi; Brett R Anderson; Emile A Bacha; Aaron Eckhauser; J William Gaynor; Eric M Graham; Benjamin Goot; Jeffrey P Jacobs; Rija John; Jonathan R Kaltman; Kirk R Kanter; Carlos M Mery; L LuAnn Minich; Richard Ohye; David Overman; Christian Pizarro; Geetha Raghuveer; Marcus S Schamberger; Steven M Schwartz; Shanthi L Narasimhan; Michael D Taylor; Ke Wang; Jane W Newburger
Journal:  J Am Coll Cardiol       Date:  2021-05-18       Impact factor: 24.094

6.  Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart Disease.

Authors:  David W Brown; Colleen Mangeot; Jeffrey B Anderson; Laura E Peterson; Eileen C King; Stacey L Lihn; Steven R Neish; Craig Fleishman; Christina Phelps; Samuel Hanke; Robert H Beekman; Carole M Lannon
Journal:  J Am Heart Assoc       Date:  2016-01-11       Impact factor: 5.501

7.  Translation and Validation of the Boston Technical Performance Score in a Developing Country.

Authors:  Leonardo A Miana; Meena Nathan; Davi Freitas Tenório; Valdano Manuel; Gustavo Guerreiro; Natália Fernandes; Carolina Vieira de Campos; Paula V Gaiolla; Renata Sá Cassar; Aida Turquetto; Luciana Amato; Luiz Fernando Canêo; Larissa Leitão Daroda; Marcelo Biscegli Jatene; Fabio B Jatene
Journal:  Braz J Cardiovasc Surg       Date:  2021-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.